Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17

Movement Disorders

Volumn 21, Issue 6, 2006, Pages 872-875

  Salvatore, Elena ^a   Varrone, Andrea ^b   Sansone, Valeria ^a   Nolano, Maria ^c   Bruni, Amalia C ^d   De Rosa, Anna ^a   Santoro, Lucio ^a   Pappatà, Sabina ^a   Filla, Alessandro ^a   De Michele, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c IRCCS   (Italy)

^d Regional Neurogenetic Center AS6   (Italy)

Author keywords

123I FP CIT SPECT; Nigrostriatal dopaminergic pathway; SCA17; Spinocerebellar ataxia

Indexed keywords

ADENINE; CYTOSINE; DOPAMINE TRANSPORTER; GUANINE; LEVODOPA; NORTROPANE DERIVATIVE; TATA BINDING PROTEIN;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FAMILY; FEMALE; HETEROZYGOTE; HUMAN; MALE; NEUROIMAGING; NIGRONEOSTRIATAL SYSTEM; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT;

CORPUS STRIATUM; HUMANS; SPINOCEREBELLAR ATAXIAS; SUBSTANTIA NIGRA; TATA-BOX BINDING PROTEIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33745838247     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20827     Document Type: Article

References (17)

1. Nakamura K, Jeong SY, Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001; 10: 1441-1448.
2. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
3. Wu YR, Lin HY, Chen CM, et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet 2004;65:209-214.
4. Bruni AC, Takahashi-Fujigasaki J, Maltecca F, et al. Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch Neurol 2004;61:1441-1443.
5. Rolfs A, Koeppen AH, Bauer I, et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 2003;54:367-375.
6. Toyoshima Y, Yamada M, Onodera O, et al. SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol 2004; 55:281-286.
7. Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord 2003;18:1415-1423.
8. Maltecca F, Filla A, Castaldo I, et al. Intergenerational instability and marked anticipation in SCA-17. Neurology 2003;61: 1441-1443.
9. Trouillas P, Takayanagi T, Haller M, et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 1997;145:205-211.
10. Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T, Dystonia Study Group. Rating scales for dystonia: a multicenter assessment. Mov Disord 2003;18:303-312.
11. Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease, vol. 2. Florham Park, NJ: MacMillian Health Care Information; 1987. p 153-163.
12. Lane RD, Glazer WM, Hansen TE, Berman WH, Kramer SI. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. J Nerv Ment Dis 1985;173:353-357.
13. 123I]FP-CIT binding in SCA2 patients without parkinsonism. Ann Neurol 2004;55:426-430.
14. Gunther P, Storch A, Schwarz J, Sabri O, Steinbach P, Wagner A, Hesse S. Basal ganglia involvement of a patient with SCA 17-a new form of autosomal dominant spinocerebellar ataxia. J Neurol 2004;251:896-897.
15. Yen TC, Tzen KY, Chen MC, et al. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers. Nucl Med 2002;43:153-159.
16. 123I-FP-CIT SPECT striatal uptake. Mov Disord 2000;15:692-698.
17. Van Laere K, De Ceuninck L, Dom R, et al. Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1. Eur J Nucl Med Mol Imaging 2004;31:1119-1127.